A novel immune-metabolic prognostic model stratifies survival and personalizes therapy in hepatocellular carcinoma
{{output}}
Background: The etiology of HCC is multifactorial, with pathogenesis involving immune and metabolic pathways. This study developed a prognostic model based on immune- and metabolism-related genes (IMRGs) to improve personalized H... ...
